E-LIB Suche - Ergebnisse für: Kairisto, Veli

1

S155: PROGNOSTIC FACTORS FOR 3-YEAR MAJOR MOLECULAR RESPONS..:

Pfirrmann, Markus ; Mahon, Francois-Xavier ; Dulucq, Stéphanie...
HemaSphere. 7 (2023) S3 - p. e230884b , 2023

Link: https://doi.org/10.1097/..

2

S159: HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH CHRON..:

Efficace, Fabio ; Mahon, Francois-Xavier ; Richter, Johan...
HemaSphere. 7 (2023) S3 - p. e0972454 , 2023

Link: https://doi.org/10.1097/..

3

Tool evaluation for the detection of variably sized indels ..:

Wang, Ning ; Lysenkov, Vladislav ; Orte, Katri...
PLOS Computational Biology. 18 (2022) 2 - p. e1009269 , 2022

Link: https://doi.org/10.1371/..

4

Gene fusions and oncogenic mutations in MLH1 deficient and ..:

Ukkola, Iiris ; Nummela, Pirjo ; Kero, Mia...
Virchows Archiv. 480 (2022) 4 - p. 807-817 , 2022

Link: https://doi.org/10.1007/..

5

Standardization of molecular monitoring of CML: results and..:

White, Helen E. ; Salmon, Matthew ; Albano, Francesco...
Leukemia. 36 (2022) 7 - p. 1834-1842 , 2022

Link: https://doi.org/10.1038/..

6

Efficacy of conventional‐dose cytarabine, idarubicin and th..:

Kolonen, Aarne ; Sinisalo, Marjatta ; Huhtala, Heini...
European Journal of Haematology. 109 (2022) 3 - p. 257-270 , 2022

Link: https://doi.org/10.1111/..

7

Measurable residual disease assessment by qPCR in periphera..:

Juul‐Dam, Kristian Løvvik ; Ommen, Hans B. ; Nyvold, Charlotte G....
British Journal of Haematology. 190 (2020) 2 - p. 198-208 , 2020

Link: https://doi.org/10.1111/..

8

Arpp19 Promotes Myc and Cip2a Expression and Associates wit..:

Mäkelä, Eleonora ; Löyttyniemi, Eliisa ; Salmenniemi, Urpu...
Cancers. 11 (2019) 11 - p. 1774 , 2019

Link: https://doi.org/10.3390/..

9

Assessment of molecular remission rate after bortezomib plu..:

Silvennoinen, Raija ; Kairisto, Veli ; Pelliniemi, Tarja‐Terttu...
British Journal of Haematology. 160 (2012) 4 - p. 561-564 , 2012

Link: https://doi.org/10.1111/..

10

Chronic Myeloid Leukemia Patients in Prolonged Remission fo..:

Kreutzman, Anna ; Rohon, Peter ; Faber, Edgar...
PLoS ONE. 6 (2011) 8 - p. e23022 , 2011

Link: https://doi.org/10.1371/..

11

ETS‐related gene ERG expression in AML patients is signific..:

Hämäläinen, Mauri ; Juvonen, Vesa ; Häikiö, Satu...
European Journal of Haematology. 85 (2010) 4 - p. 361-362 , 2010

Link: https://doi.org/10.1111/..

12

Depth of response assessed by quantitative ASO‐PCR predicts..:

Putkonen, Mervi ; Kairisto, Veli ; Juvonen, Vesa...
European Journal of Haematology. 85 (2010) 5 - p. 416-423 , 2010

Link: https://doi.org/10.1111/..

13

Wilms tumour gene 1 overexpression in bone marrow as a mark..:

Hämäläinen, Mauri M. ; Kairisto, Veli ; Juvonen, Vesa...
European Journal of Haematology. 80 (2008) 3 - p. 201-207 , 2008

Link: https://doi.org/10.1111/..

14

Stem cell transplantation in poor‐risk chronic lymphocytic ..:

Itälä, Maija ; Huhtinen, Anna‐Riina ; Juvonen, Vesa...
European Journal of Haematology. 81 (2008) 2 - p. 100-106 , 2008

Link: https://doi.org/10.1111/..

15

Reference Intervals for Serum Creatinine Concentrations: As..:

the IFCC Committee on Reference Intervals and Decision Limits (C-RIDL) ; Panteghini, Mauro ; Kairisto, Veli...
Clinical Chemistry. 54 (2008) 3 - p. 559-566 , 2008

Link: https://doi.org/10.1373/..